Ansa Biotechnologies is a company that develops a DNA synthesis technology intended to simplify the biological research process. It accelerates innovation in biological research and engineering based on polymerase-nucleotide conjugates that have the ability to extend a DNA molecule. The company allows the healthcare industry to fasten defined nucleotide additions research by TdT while unlocking the potential of enzymatic de novo DNA synthesis.